CURN vs PPGN: Side-by-Side Comparison
Compare CURATIS N AG (CURN) and PolyPeptide Group AG (PPGN) side by side: market cap CHF 114.46M vs CHF 1.59B. Financials, growth and model signals on Bullrun.
| Metric | CURN | PPGN |
|---|---|---|
| Company | CURATIS N AG | PolyPeptide Group AG |
| Country / Exchange | Switzerland · SW | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | CHF 114.46M | CHF 1.59B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | CHF 10.80M | CHF 391.87M |
| Revenue growth YoY | +56.6% | +15.7% |
| Net income | CHF -1.42M | CHF -21.17M |
| Gross margin | 26.3% | 17.0% |
| Diluted EPS | -0.28 | -0.64 |